SCHEMBL23794643

SCHEMBL23794643

CCOC(=O)c1cnc(-c2cccc(OC)c2)s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 2/20 0.63
DBF4 Q9UBU7 2/20 0.63
HSD17B1 P14061 1/20 0.57
HSD17B2 P37059 1/20 0.57
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 4/20 0.57
HSD17B10 Q99714 4/20 0.57
HPGD P15428 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
USP2 O75604 1/20 0.57
HDAC3 O15379 3/20 0.55
HDAC4 P56524 3/20 0.55
HDAC1 Q13547 3/20 0.55
HDAC7 Q8WUI4 3/20 0.55
HDAC2 Q92769 3/20 0.55
HDAC10 Q969S8 3/20 0.55
HDAC11 Q96DB2 3/20 0.55
HDAC8 Q9BY41 3/20 0.55
HDAC6 Q9UBN7 3/20 0.55
HDAC9 Q9UKV0 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23794663 0.86 CDC7 (0.67) CDC7DBF4HSD17B1HSD17B2ALDH1A1
SCHEMBL4894167 0.85 CDC7 (0.73) CDC7DBF4ALDH1A1KDM4EHSD17B10
SCHEMBL18974750 0.84 NPC1 (0.68) CDC7DBF4ALDH1A1KDM4EHPGD
SCHEMBL23702766 0.84 CDC7 (0.64) CDC7DBF4ALDH1A1HPGDSMN1; SMN2
SCHEMBL23794764 0.84 CDC7 (0.64) CDC7DBF4ALDH1A1KDM4EHPGD
SCHEMBL29994313 0.84 CDC7 (0.64) CDC7DBF4ALDH1A1HPGDSMN1; SMN2
SCHEMBL22637527 0.83 HSD17B1 (0.60) HSD17B1HSD17B2ALDH1A1KDM4EHSD17B10
SCHEMBL2225549 0.83 CDC7 (0.79) CDC7DBF4ALDH1A1KDM4EHSD17B10
SCHEMBL23794687 0.81 MAPT (0.64) CDC7DBF4ALDH1A1KDM4EHPGD
SCHEMBL23794676 0.81 CDC7 (0.60) CDC7DBF4HSD17B1HSD17B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220009918-A1 Chemical Compounds GLAXOSMITHKLINE IP DEV LTD (GB) 2022-01-13 US disclosed
US-20220009918-A1 Chemical Compounds GLAXOSMITHKLINE IP DEV LTD (GB) 2022-01-13 US disclosed
EP-3877384-A1 CHEMICAL COMPOUNDS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2021-09-15 EP disclosed
CN-112969698-A Chemical compound 葛兰素史密斯克莱知识产权发展有限公司 2021-06-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009918-A1 Chemical Compounds HPGDS, PTGS1, PTGER1 CDC7 3467/4885DBF4 2198/4885HSD17B1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.